Evoke Pharma Inc expected to post a loss of 50 cents a share - Earnings Preview

Evoke Pharma

12/03/2024 20:54

* Evoke Pharma Inc  EVOK.OQ   EVOK.O  is expected to show a
rise
in quarterly revenue when it reports  results on March 14 for
the period ending December 31 2023
    * The Solana Beach California-based  company is expected to
report
a 105.0% increase in revenue to $1.632 million from $796
thousand a year ago, according to the estimate from one analyst,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Evoke Pharma Inc is for
a loss
of 50 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Evoke
Pharma Inc
is $7.00​, above​ its last closing price of $0.66. ​​​

This summary was machine generated March 12 at 20:54 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)